James C. Clemmer is President & VP at Covidien plc (COV). They have made 14 open-market trades across 2 companies since 2009, most recently 2026-07-22.
CIK 0001476700
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
7 open-market purchases totalling $1.6M since 2017, against 7 sales. Across 7 scored buys the stock is up 0.1% at ninety days, and 3.0 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 43% | 71% | 43% |
| Avg Move | -2.0% | +0.1% | +0.1% |
| Alpha | -1.6% | -2.1% | -3.0% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANGO | BUY | 2025-10-09 | 2025-10-09 | $11.15 | $112K | -0.4% | +4.5% | -7.1% |
| ANGO | BUY | 2024-10-07 | 2024-10-08 | $6.03 | $121K | +4.4% | +16.8% | +51.5% |
| ANGO | BUY | 2024-04-08 | 2024-04-08 | $6.70 | $67K | -12.7% | -16.0% | -21.4% |
| ANGO | BUY | 2022-10-10 | 2022-10-11 | $15.00 | $150K | -2.6% | +5.3% | +6.6% |
| ANGO | BUY | 2022-01-11 | 2022-01-12 | $22.84 | $228K | -7.1% | -8.9% | -2.5% |
| ANGO | BUY | 2020-07-31 | 2020-08-03 | $8.26 | $330K | +7.3% | +5.8% | +19.1% |
| ANGO | BUY | 2019-10-25 | 2019-10-28 | $14.19 | $213K | +0.7% | +3.9% | -4.9% |
| ANGO | BUY | 2017-07-20 | 2017-07-21 | $15.67 | $392K | +0.6% | +6.3% | +10.6% |
| COV | SELL | 2014-11-10 | 2014-11-12 | $92.48 | $320K | N/A | N/A | N/A |
| COV | SELL | 2013-12-06 | 2013-12-09 | $67.85 | $3.0M | N/A | N/A | N/A |
| COV | SELL | 2013-05-08 | 2013-05-09 | $65.41 | $1.9M | N/A | N/A | N/A |
| COV | SELL | 2012-12-10 | 2012-12-10 | $58.00 | $4.2M | N/A | N/A | N/A |
| COV | SELL | 2012-08-07 | 2012-08-07 | $57.30 | $4.9M | N/A | N/A | N/A |
| COV | SELL | 2011-04-28 | 2011-04-29 | $56.51 | $3.8M | N/A | N/A | N/A |
| COV | SELL | 2009-11-24 | 2009-11-24 | $46.59 | $405K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.